Osaic Holdings’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Osaic Holdings’s Portfolio CRXT Stock Details CRXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,000	Closed	-$4K	–	7750
2022 Q2	$4K	Buy	+10,000	New	+$7K	﹤0.01%	6675

Other funds holding CRXT

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Osaic Holdings's CRXT Position: Q3 2022 in Review

Osaic Holdings sold out of Clarus Therapeutics Holdings, Inc. Common Stock (CRXT) in Q3 2022, closing a stake of 10,000 shares — an estimated $4K sold.

Osaic Holdings first reported a position in CRXT in Q2 2022 and held it in 1 quarter. The position peaked at $4K in Q2 2022. 2 funds tracked by Wall St. Rank hold CRXT as of Q3 2022.

Osaic Holdings reported no remaining Clarus Therapeutics Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Osaic Holdings sold 10,000 Clarus Therapeutics Holdings, Inc. Common Stock shares in Q3 2022, an estimated $4K.
Osaic Holdings first reported a position in Clarus Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Osaic Holdings's Clarus Therapeutics Holdings, Inc. Common Stock position peaked at $4K in Q2 2022.
2 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Common Stock as of Q3 2022.

Based on Osaic Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.